CDC140: A Potential Drug Target for Various Diseases (G151278)

Target Name: CCDC140

NCBI ID: G151278

CCDC140

Other Name(s): CC140_HUMAN | Coiled-coil domain containing 140 | Coiled-coil domain-containing protein 140 | CCDC140 long non-coding RNA

CDC140: A Potential Drug Target for Various Diseases

CCDC140 (CC140) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and gastrointestinal tract. It is a member of the C-type lectin family of proteins, which are involved in the recognition and binding of extracellular molecules.

One of the unique features of CCDC140 is its ability to interact with the protein PDGF-BB, which is a key regulator of cell growth and differentiation. This interaction between CCDC140 and PDGF-BB has led to the hypothesis that CCDC140 may be a drug target or biomarker for the treatment of various diseases.

CDC140 has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of CCDC140 are associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential role in disease, CCDC140 has also been shown to have potential as a drug target. Several studies have shown that blocking the activity of CCDC140 can lead to the inhibition of the growth and migration of cancer cells. This suggests that CCDC140 may be an effective target for the treatment of cancer.

Another potential use of CCDC140 as a drug target is its role in the development of autoimmune disorders. Studies have shown that CCDC140 is involved in the regulation of immune cell function and that its activity can be modulated to influence the immune response. This suggests that CCDC140 may be an effective target for the treatment of autoimmune disorders.

In conclusion, CCDC140 is a protein that has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its ability to interact with the protein PDGF-BB and its potential as a drug target make it an attractive target for the development of new treatments for these diseases. Further research is needed to fully understand the role of CCDC140 in disease and its potential as a drug.

Protein Name: CCDC140 Long Non-coding RNA

The "CCDC140 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC140 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets